Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Abdelhakam Hassan Ibrahim Ali

Neelain University, Sudan

Title: Carbapenemase production in hospital isolates of multidrug-resistant Klebsiella pneumoniae in Sudan

Biography

Biography: Abdelhakam Hassan Ibrahim Ali

Abstract

Background: Antibiotic non susceptible Bacteria have been increased and disseminated all over the world. So this resistant strain with treatment difficulty may threat the Patients lives. However the last line of treatment for such infection is antibiotic from Carbapenem family (1). One of the most virulence bacteria with pandrug resistant is Klebsiella pneumoniae  which associated with high associated with morbidity and mortality (2). In this study, the phenotypic and genotypic features of carbapenem-resistant K.pneumoniae strains isolated in some Sudanese hospitals were studded.

Methodology: Strains of K. pneumoniae resistant to at least one carbapenem (imipenem or meropenem) were collected from May, 2015 to January, 2017. Isolates were obtained from clinical samples of patients treated inside the hospitals. Carbapenem resistance was confirmed using modified Hodge test (MHT) as phenotypic test and real-time PCR for genotypic detection.

Findings: A total 96 strains of K. pneumoniae of different non duplicated isolates were obtained from following samples; urine (47), wound swab (22), sputum (16), stool (3), CSF (1), HVS (4), seminal fluid (1), peritoneal (1) and blood.

All these isolates were found to be resistant to carbapenem by disc sensitivity test and modified Hodge test (MHT) revealed 63 (65.6%) isolates were carbapenemase producers. Seventy-two percent (70/96) isolates were positive for carbapenemase genes; 59.4% (57/96) were positive for blaKPC genes, 57.3% (55/96) were positive for blaNDM genes, 37.5% (36/96) were positive for blaVIM genes and 35.4% (34/96) were positive for blaOXA-48 genes. Nineteen isolates possessed four genes (blaKPC, blaNDM, blaVIM and blaOXA-48) , fourteen isolates possessed three genes{(blaNDM, blaVIM and blaOXA-48=6), (blaKPC, blaNDM, and blaOXA-48=3), (blaKPC, blaNDM and blaVIM =3), (blaKPC, blaVIM and blaOXA-48=2)}, 27 isolates possessed two genes{(blaKPC and blaNDM =21), (blaKPC, blaOXA-48=2), (blaNDM and blaVIM=3), (blaNDM and blaOXA-48=1)}, 10 isolates possessed only one gene (blaKPC=8, blaOXA-48=1 and blaVIM =1) and the remaining 26 isolates were free from these genes.

Conclusion & Recommendation: In Sudan, the most common type of carbapenemase gene multidrug-resistant K. pneumoniae is KPC. Co-production of KPC, VIM, NDM and OXA-48 genes are found in K. pneumoniae. To our knowledge, this study was done for the first time in Sudan. Therefore, it is necessary to determine carbapenem resistance in K.pneumoniae isolates and take essential infection control precautions to avoid spread of this resistance.